Abstract
Background: Use of Guideline-Directed Medical Therapy (GDMT) in patients with Heart Failure reduced Ejection Fraction (HFrEF) has been proven to reduce mortality and morbidity. The role of the Wearable Cardioverter Defibrillator (WCD) in new HFrEF patients is uncertain (AHA Guideline II-B). The
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
